http://www.healio.com/infectious-disease/respiratory-infections/news/online/%7Ba71bec67-beae-4d07-913a-c95dae42a66f%7D/motavizumab-reduces-rsv-hospitalizations-in-native-american-infants
Posted by Rob Lambkin-Williams
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment